| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | GABAERON INC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 000 | 3 | NIH | 2/28/2022 | $0 |
| | 2022 | 2020 | GABAERON INC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG060873 | Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4 | 000 | 3 | NIH | 1/27/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,086,082 ) |
| | 2021 | 2021 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 000 | 3 | NIH | 12/4/2020 | $1,086,082 |
|
| Issue Date FY: 2020 ( Subtotal = $2,028,166 ) |
| | 2020 | 2020 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG060873 | Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4 | 000 | 3 | NIH | 8/20/2020 | $948,584 |
| | 2020 | 2020 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 000 | 2 | NIH | 12/9/2019 | $1,079,582 |
| | 2020 | 2020 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 002 | 2 | NIH | 3/7/2020 | $67,712 |
| | 2020 | 2019 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 001 | 1 | NIH | 3/7/2020 | -$67,712 |
|
| Issue Date FY: 2019 ( Subtotal = $1,324,676 ) |
| | 2019 | 2019 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 000 | 1 | NIH | 4/22/2019 | $342,592 |
| | 2019 | 2019 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG063691 | Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | 001 | 1 | NIH | 5/1/2019 | $0 |
| | 2019 | 2019 | GABAERON, INC. | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG060873 | Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4 | 000 | 2 | NIH | 9/6/2019 | $982,084 |
|
| Issue Date FY: 2018 ( Subtotal = $292,422 ) |
| | 2018 | 2018 | GABAERON, INC. | 325 BERRY ST APT 327 | SAN FRANCISCO | CA | 94158-1587 | SAN FRANCISCO | USA | R44AG060873 | Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4 | 000 | 1 | NIH | 8/6/2018 | $292,422 |
|
|
